SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors
Background Calprotectin is a major S100 leucocyte protein, associated with disease activity in rheumatoid arthritis (RA) patients. Calprotectin is a potentially biomarker more sensitive of disease activity than conventional acute-phase reactans.
Autores Principales: | Inciarte-Mundo, J., Hernández, M., Ruiz-Esquide, V., Ramírez, J., Cuervo, A., Amaya, J., Pascal, M., Yagüe, J., Cañete, J., Sanmarti, R. |
---|---|
Formato: | Objeto de conferencia (Conference Object) |
Lenguaje: | Inglés (English) |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/26451 https://doi.org/10.1136/annrheumdis-2015-eular.3394 |
Ejemplares similares
-
Multiple sclerosis in the tropics: genetic association to STR's loci spanning the HLA and TNF
por: Palacio, L G, et al.
Publicado: (2002) -
Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis
por: Romero Sánchez, Consuelo, et al.
Publicado: (9/4/) -
American depositary received "ADR"
por: Ramos Forero, Jessica, et al.
Publicado: (2013) -
Optimum allocation of sample sizes in stratified random sampling via mathematical programming
por: Sánchez, Alfonso, et al.
Publicado: (2010) -
Optimum allocation of sample sizes in stratified random sampling via mathematical programming
por: Sánchez, Alfonso, et al.
Publicado: (2010)